Product Recall

Torrent Pharmaceuticals has expanded its voluntary recall of its losartan potassium tablets to include five additional lots due to unacceptable amounts of N-Nitroso-N-methyl-4-aminobutyric acid, or NMBA, according to an FDA press release.

The FDA has designated Edwards Lifesciences’ product recall of a transcatheter heart valve delivery system as a class 1 recall, the most serious kind. The recall affects 1,585 systems manufactured and distributed since Jan. 23.

The FDA has designated Abbott’s product recall of an implantable cardioverter defibrillator as a class 1 recall, the most serious kind. The recall affects 108 devices manufactured and distributed between April 5 and June 14.